Now Seeing Patients 18-65 in Beachwood, Ohio
A new study to test whether taking BI 1358894 for eight weeks helps adults with post-traumatic stress disorder is now available at Insight Clinical Trials in Beachwood.
This study is open to people aged 18 to 65 who have been diagnosed with post-traumatic stress disorder. The purpose of this study is to find out whether a medicine called BI 1358894 improves symptoms in people with post-traumatic stress disorder.
Participants are put into two groups randomly. Participants take BI 1358894 or placebo as tablets every day for two months. Placebo tablets look like BI 1358894 tablets but do not contain any medicine.
Participants are in the study for about three months. During this time, they visit the study site about eight times and get about four phone calls from the trial staff. During the study, participants answer questions in interviews and complete questionnaires so the doctors can check whether their symptoms change.
The doctors also regularly check participants' health and take note of any unwanted effects.
To pre-qualify for this study, you must:
• Be 18 to 65 years of age
• Have been diagnosed with PTSD
• Have experienced the traumatic event at
least 3 months before beginning the study
Additional criteria may apply. All study-related visits, tests, and drugs will be provided at no cost. Compensation and transportation is available to all who participate.
There is no definitive cure for PTSD, but there are many types of treatment that can alleviate the symptoms. There are various therapy techniques, as well as evidence that medication may be useful for people struggling with symptoms of PTSD.
Insight Clinical Trials is one of the leading independent medical research institutes in Northern Ohio. With our patients and their families as our priority, we are dedicated to safe research specializing in mental health conditions such as PTSD, depression, anxiety, Alzheimer’s disease, dementia and other neurological disorders. Our team of medical experts stands ready to help participants access the latest medical interventions and healthcare. Contact us today to learn more.
Comments